Month: August 2024

PETAH-TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, today reported financial results for the second quarter of 2024. “We report today the results of another very strong quarter of margin expansion and strong growth all across the business, with the second quarter of 2024 breaking a record, being our first ever non-peak quarter with GMV trading above the $1 billion mark,” said Amir Schlachet, Founder and CEO of Global-e. “We believe these strong results, and our solid growth outlook towards the second half of 2024 and beyond, are the outcome of solid execution along all our strategic goals by our dedicated team around the globe, as we continue on our path to power better global e-commerce, transforming how merchants and shoppers across...

– Enrollment complete in aplitabart randomized colorectal cancer clinical trial; top-line PFS results expected by the end of 1Q25 – – Second dose cohort cleared in imvotamab rheumatoid arthritis clinical trial – – First dose cohort cleared in imvotamab systemic lupus erythematosus clinical trial – MOUNTAIN VIEW, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) —  IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced its financial results for the fiscal quarter ended June 30, 2024 and provided an update on recent developments. “We continue to make significant progress in the clinical development of our two lead product candidates,” said Fred Schwarzer, Chief Executive Officer of IGM Biosciences. “We are pleased to have completed enrollment of 127 patients...

Completed Construction of New NexoBrid® Manufacturing Facility €16.25 Million EIC Funding Expedites EscharEx® Development for Diabetic Foot Ulcers, Significantly Expanding the Addressable Market; Phase III Study for Venous Leg Ulcers to Begin in H2 2024 $25 Million Strategic Investment Led by Mölnlycke Health Care Conference Call Today, August 14 at 8:30am Eastern Time YAVNE, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the second quarter ended June 30, 2024, and provided a corporate update. “This has been another strong quarter for MediWound as we continue to successfully execute our strategic plan,” said Ofer Gonen, Chief Executive Officer of MediWound. “We have completed construction...

OTTAWA, Ontario, Aug. 14, 2024 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced its financial results for the three and six-month periods ended June 30, 2024. All amounts are in Canadian dollars and reported under International Financial Reporting Standards (IFRS) unless otherwise noted. “I am pleased with our financial and operating performance for the second quarter,” commented Dan Goldberg, Telesat’s President and CEO. “We remain on track to meet our 2024 guidance and, as a result of our continued disciplined execution, delivered industry-leading Adjusted EBITDA margins1, high capacity utilization, a substantial contractual backlog2 of $1.1 billion, and a cash balance of $1.4 billion.” Goldberg added: “Our focus this year remains twofold. First,...

Alignment with regulatory agencies following End-of-Phase 2 meetings for the prophylactic development of deucrictibant; global startup activities of CHAPTER-3, pivotal Phase 3 study of deucrictibant for the prevention of hereditary angioedema (HAE) attacks, underway Enrollment of RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, progressing as planned Executing from a strong financial position with cash and cash equivalents of €344 million as of June 30, 2024ZUG, Switzerland, Aug. 14, 2024 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the financial results for the second quarter ended June 30, 2024, and provided...

OR YEHUDA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) — Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC) (“the Company”), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, announced today its financial results for the second quarter and first half ended June 30, 2024. Summary Results for the Second Quarter 2024 (USD in millions, except per share data)                 GAAP     Non-GAAP    Q2 2024 Q2 2023 % Change   Q2 2024 Q2 2023 % ChangeRevenues $ 136.3   $ 137.6   (1.0%)   $ 136.3   $ 137.6   (1.0%)Gross profit $ 38.8   $ 40.3   (3.6%)   $ 40.1   $ 41.6   (3.7%)Gross margin   28.5%     29.3%   (80) bps     29.4%     30.3%   (90) bpsOperating income $ 15.0   $ 15.4   (2.6%)   $ 18.2   $ 18.4   (1.2%)Operating margin   11.0%     11.2%   (20)...

Preliminary Q2 2024 results and quarterly cash dividend to $0.27 per shareHamilton, Bermuda, August 14, 2024, SFL Corporation Ltd. (“SFL” or the “Company”) today announced its preliminary financial results for the quarter ended June 30, 2024. Highlights82nd consecutive quarterly dividend declared, $0.27 per share Net profit of $20.6 million, or $0.16 per share in the second quarter Received charter hire1 of $198.8 million in the quarter, including $4.4 million of profit share Adjusted EBITDA2 of $123.3 million from consolidated subsidiaries, plus $7.8 million adjusted EBITDA2 from associated companies New five year time charters for three 10,600 teu and four 8,700 teu vessels to Maersk adding approximately $485 million of backlog Delivery of the newbuild LR2 product tanker SFL Tucana in June with two additional vessels due for delivery...

Updates fiscal 2024 outlook including expected net new center openings Second Quarter Fiscal 2024 versus 2023Net new centers increased 5.6% to 1,059 total centers in 45 states System-wide sales of $260.2 million increased 2.3% Total revenue of $59.9 million increased 1.3% Same-store sales increased 1.6% GAAP net income of $6.0 million increased 7.3% Adjusted net income of $7.3 million increased 4.0% Adjusted EBITDA of $20.6 million decreased 2.6%PLANO, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) — Today, European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States, reports financial results for the 13 and 26 weeks ended July 6, 2024. In a separate release today, European Wax Center announced that its Board of Directors has appointed David Berg...